JPS60181022A - Anti-inflammatory and analgesic composition for mucosa - Google Patents
Anti-inflammatory and analgesic composition for mucosaInfo
- Publication number
- JPS60181022A JPS60181022A JP59037635A JP3763584A JPS60181022A JP S60181022 A JPS60181022 A JP S60181022A JP 59037635 A JP59037635 A JP 59037635A JP 3763584 A JP3763584 A JP 3763584A JP S60181022 A JPS60181022 A JP S60181022A
- Authority
- JP
- Japan
- Prior art keywords
- inflammatory
- dried
- extract
- water
- mucosa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【発明の詳細な説明】
〔技術分野〕
本発明は、漢方生薬による粘膜に対する消炎・鎮痛性組
成物に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Technical Field] The present invention relates to an anti-inflammatory and analgesic composition for mucous membranes using herbal herbal medicines.
粘膜の痛み、特にカゼ、扁桃腺炎による咽喉の痛みを訴
える人は少なくなく、近年のカゼは特にその傾向が強く
なっていると言われる。Many people complain of mucous membrane pain, especially sore throats caused by colds and tonsillitis, and it is said that this tendency has become particularly strong in recent years.
ところで、咽喉痛や扁桃腺炎等の粘膜の痛み、炎症は、
テトラサイタリン系の抗生物質やペニシリン系、セファ
ロスポリン系などの抗生物質で効率良(治癒されるよう
になってきた。By the way, mucous membrane pain and inflammation such as sore throat and tonsillitis are
It has become effective (curable) with antibiotics such as tetracytalin, penicillin, and cephalosporin.
しかし反面、ウィルスにより引き起こされるカゼの場合
、必ずしも抗生物質が有効に働かず、咽喉の痛みが長期
にわたる場合も少なくないことや、また、体の抵抗力の
衰えた者や長期間抗生物質を飲み続けた者は菌交耐症に
かかるなど、その他重篤な副作用をまねくことも少なく
ない。However, on the other hand, in the case of colds caused by viruses, antibiotics do not necessarily work effectively and the sore throat often persists for a long time. Those who continue using the drug often develop bacterial cross-resistance and other serious side effects.
従って、咽喉痛等の粘膜癌、扁桃腺炎などの粘膜の炎症
を緩和し、抗生物質の長期連用をさけることが試みられ
ている。かかる試みとして、初期や軽度の咽喉痛の治療
に甘草の水製エキスのアンプル等が販売され、注目をあ
びている。しかしながら、甘草単味による効果は必ずし
も速効性、有効性の点で認めがたい場合も少なくないの
が実情である。Therefore, attempts have been made to alleviate mucosal cancers such as sore throats and mucosal inflammations such as tonsillitis, and to avoid long-term use of antibiotics. As part of such an attempt, ampoules of aqueous licorice extract have been sold for the treatment of initial or mild sore throats, and are attracting attention. However, the reality is that in many cases it is difficult to recognize the effects of licorice alone in terms of immediate effect and effectiveness.
かかる実情下に本発明者会は種々の研究を重ねて来たと
ころ、甘草の他に黄蜀葵及び山査子の3味を併用するこ
とによって、速やかに、かつ顕著に粘膜痛及び粘膜炎症
が緩和されることを見い出した。Under these circumstances, the Society of Inventors has conducted various studies and has found that mucosal pain and mucosal inflammation can be rapidly and significantly alleviated by using licorice in combination with the three flavors of Aspergillus orientalis and Sanshuzi. I discovered that.
本発明はかかる知見に基づいて完成されたもので、黄蜀
葵、山査子、甘草の3味を有効成分として含有してなる
粘膜に対する消炎・鎮痛性組成物に関するものである。The present invention has been completed based on this knowledge, and relates to an anti-inflammatory and analgesic composition for mucous membranes, which contains the three flavors of Aspergillus orientalis, Porphyra spp., and Licorice as active ingredients.
本発明に用いられる黄蜀葵は、アオイ科(Fam−41
y Malvaceae )の植物、トロロアオイ (
llibis−cus manihot LINNAE
US、 )の根を乾燥したものである。The yellow hollyhock used in the present invention is of the Malvaceae family (Fam-41
y Malvaceae) plant, the plant
llibis-cus manihot LINNAE
US, ) roots are dried.
また、山査子は、バラ科(Family Rosace
ae)の植物、サンザシ(Crataegus cun
eata )の果実、あるいはその乾燥物である。In addition, Yamaseko is a member of the Rosaceae family (Family Rosaceae).
ae) plant, hawthorn (Crataegus cun)
eater) fruit or its dried product.
は草は、マメ科(Fas目y Le5minosae)
の植物、カンデラ(Glycyrrhiga ural
ensis) 、その他の同層〔例えば、Glycyr
rhiza glabra)の根を乾燥したものである
。The grass is a member of the Fabaceae family (order Fasales, Le5minosae).
Candela (Glycyrrhiga ural)
Glycyr ensis), other colayers [e.g. Glycyr
rhiza glabra) is dried.
これら有効成分は、通常そのエキス又は流エキスとして
用いられる。These active ingredients are usually used as their extracts or liquid extracts.
黄蜀葵のエキス又は流エキスとしては、好ましくは水に
より抽出されたものがあげられる。水抽出に際しては、
必要に応じ加熱抽出してもよい。Preferred examples of the extract or liquid extract of Aspergillus orientalis include those extracted with water. For water extraction,
Extraction may be performed by heating if necessary.
山査子のエキス又は流エキスとしては、水を用いて抽出
(温度55℃以下)したもの、生の果実を圧搾、ミキサ
ー、ジューサー等により、汁を取り出したものが好まし
い。Preferable examples of the extract or liquid extract of Phytophthora japonica include those extracted using water (at a temperature of 55° C. or less), those obtained by squeezing the raw fruit, and extracting the juice using a mixer, juicer, etc.
甘草のエキス又は流エキスとしては、水、強極性有機溶
媒又はこれらの混合溶媒で溶出されたエキス、特に水及
びエタノールで抽出された流エキスが用いられる。As the licorice extract or liquid extract, an extract eluted with water, a strong polar organic solvent, or a mixed solvent thereof, particularly a liquid extract extracted with water and ethanol is used.
各成分の組成比は、通常、甘草:黄蜀葵:山査子=t:
O,S〜540.5〜10(重量比)程度である。The composition ratio of each component is usually licorice: Huangshuoi: Yamasako = t:
O,S~540.5~10 (weight ratio).
本発明の粘膜に対する消炎・鎮痛性組成物においては、
これら3味の生薬以外に必要に応じ、黄連、黄柏、南天
実、南天葉、コロンボ等の生薬を加えてもよく、また抗
菌作用のある化学医薬品を配合してもよい。In the anti-inflammatory/analgesic composition for mucous membranes of the present invention,
In addition to these three herbal medicines, other herbal medicines such as Huangren, Huangbai, Nantenmi, Nantenha, Colombo, etc. may be added as required, and chemical drugs with antibacterial activity may be added.
本発明の粘膜に対する消炎・鎮痛性組成物の活性成分は
、いずれも古来から使用されている漢方薬であり、それ
らの安全性はすでに確立されているものである。The active ingredients of the anti-inflammatory and analgesic composition for mucous membranes of the present invention are all Chinese herbal medicines that have been used since ancient times, and their safety has already been established.
本発明において、粘膜としては、口腔壁、消化管壁等が
あげられ、本発明組成物はかがる器官における消炎・鎮
痛作用を有しているので、胃潰瘍、咽喉痛、扁桃腺炎等
の予防・治療剤、症状の緩和剤などとして用いられる。In the present invention, examples of mucous membranes include the oral cavity wall and the gastrointestinal wall, and since the composition of the present invention has an anti-inflammatory and analgesic effect on the mucous organs, it can be used to treat gastric ulcers, sore throats, tonsillitis, etc. It is used as a prophylactic/therapeutic agent, a symptom reliever, etc.
従って、本発明の粘膜に対する消炎・鎮痛性組成物は、
消炎・鎮痛剤、所謂健康補助食品などとして使用される
。Therefore, the anti-inflammatory and analgesic composition for mucous membranes of the present invention,
It is used as an anti-inflammatory and painkiller, and as a so-called health supplement.
本発明の粘膜に対する消炎・鎮痛性組成物は、好ましく
は製薬上許容されうる担体、賦形剤、希釈剤などの製薬
用添加剤と混合してシロップ剤、ドリンク剤、トローチ
などの形態とされる。また、水アメ等に配合して所謂健
康補助食品の形態としてもよい。The anti-inflammatory and analgesic composition for mucous membranes of the present invention is preferably mixed with pharmaceutical additives such as pharmaceutically acceptable carriers, excipients, and diluents to form syrups, drinks, troches, and the like. Ru. It may also be mixed with starch syrup or the like to form a so-called health supplement.
各有効成分の配合量は、担体、賦形剤、希釈剤などの製
薬用添加剤中、それぞれ0.02〜60重量%程度、好
ましくは041〜50重量%程度である。The blending amount of each active ingredient is about 0.02 to 60% by weight, preferably about 0.41 to 50% by weight, in pharmaceutical additives such as carriers, excipients, and diluents.
本発明の粘膜に対する消炎・鎮痛性組成物を消炎・鎮痛
剤として使用する場合は、ヒトを含む哺乳動物に対して
、通常経口的に投与される。投与量は、消炎・鎮痛作用
を発揮する咽喉痛を緩和する量であればよく、投与対象
動物、症状、剤型などによって変動しうるが、一般に経
口剤の場合、生薬粉末として各lθ〜1000mg程度
、好ましくは50〜500mgである。また、エキスと
しては、生薬に換算して、上記の量を含有するに相当す
る量である。投与回数は1日1〜3回の範囲で適宜選択
しうる。When the anti-inflammatory/analgesic composition for mucous membranes of the present invention is used as an anti-inflammatory/analgesic, it is usually administered orally to mammals including humans. The dosage may be any amount that relieves sore throat by exerting anti-inflammatory and analgesic effects, and may vary depending on the animal to be administered, symptoms, dosage form, etc., but in general, in the case of oral preparations, each lθ to 1000 mg of crude drug powder is used. degree, preferably 50 to 500 mg. In addition, the amount of the extract is equivalent to the above-mentioned amount in terms of herbal medicine. The frequency of administration can be appropriately selected within the range of 1 to 3 times a day.
以下に本発明の漢方生薬による粘膜に対する消炎・鎮痛
性組成物がいかに有効であるかを実施例および実験例を
挙げて証明する。The effectiveness of the anti-inflammatory and analgesic composition for mucous membranes using herbal herbal medicines of the present invention will be demonstrated below by giving examples and experimental examples.
実施例1 (水アメ) 麦芽水アメ 80g 麦芽糖 15g 果糖 5g 以上の水アメ剤ベースに下記生薬組成物を配合した。Example 1 (water syrup) Malt starch syrup 80g Maltose 15g Fructose 5g The following crude drug composition was blended into the above starch syrup base.
甘草水製エキス 0.5g 黄蜀発水製エキス Ig 山査子生果汁 2g 実施例2(1′リンク剤) ハチミツ 2g ブドウ糖 3g 水 95g 以上のドリンク剤ベースに下記生薬組成物を配合した。Licorice water extract 0.5g Huangshu Fasui Extract Ig Yamasako raw juice 2g Example 2 (1' linking agent) Honey 2g Glucose 3g Water 95g The following crude drug composition was blended into the above drink base.
甘草エタノールエキス 0.4g
黄蜀発水流エキス 10g(原生薬1g)山査子水流エ
キス 5g(原生薬2g)比較例1
実施例1において甘草水製エキスの代わりにブドウ糖0
.5gを用いた水アメ剤を得た。Licorice ethanol extract 0.4g Huangshu water extract 10g (1g of herbal medicine) Sanshazi watery extract 5g (2g of herbal medicine) Comparative example 1 In Example 1, 0 glucose was used instead of the licorice water extract.
.. A starch syrup using 5 g was obtained.
比較例2
実施例2において山査子水流エキスの代わりに5%ブド
ウ糖液5gを用いたドリンク剤を得た。Comparative Example 2 A drink was obtained using 5 g of 5% glucose solution in place of the Aqueduct extract in Example 2.
実験例
カゼによる咽喉痛を訴える者20名に実施例1及び2、
並びに比較例1及び2の製剤又は食品を投与し、2日後
にその症状を調べた結果は次表の通りである。Experimental Example Examples 1 and 2 were given to 20 people who complained of sore throat due to colds.
The formulations or foods of Comparative Examples 1 and 2 were administered, and the symptoms were examined two days later. The results are shown in the following table.
以上の実施例により、明らかに本則カー有効であること
が証明された。The above examples clearly prove that the basic car is effective.
Claims (1)
対する消炎・鎮痛性組成物。 (2)甘草が水又は強極性有機溶媒抽出エキスの形態で
ある特許請求の範囲第+11項記載の粘膜に対する消炎
・鎮痛性組成物。 (3)黄蜀葵が水抽出エキスの形態である特許請求の範
囲第111項又は第(2)項記載の粘膜に対する消炎・
鎮痛性組成物。 (4)山査子が55℃以下の水で抽出したエキスの形態
である特許請求の範囲第+1)項、第(2)項又は第(
3)項記載の粘膜に対する消炎・鎮痛性、組成物。[Scope of Claims] +11 An anti-inflammatory and analgesic composition for mucous membranes, which contains Kegusa oleracea, Aspergillus spp. (2) The anti-inflammatory and analgesic composition for mucous membranes according to claim 11, wherein the licorice is in the form of water or a strong polar organic solvent extract. (3) Anti-inflammatory treatment for mucous membranes according to claim 111 or (2), wherein Astragalus is in the form of a water extract.
Analgesic composition. (4) Claim No. +1), (2) or
3) The composition having anti-inflammatory and analgesic properties for mucous membranes as described in section 3).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59037635A JPS60181022A (en) | 1984-02-28 | 1984-02-28 | Anti-inflammatory and analgesic composition for mucosa |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59037635A JPS60181022A (en) | 1984-02-28 | 1984-02-28 | Anti-inflammatory and analgesic composition for mucosa |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS60181022A true JPS60181022A (en) | 1985-09-14 |
Family
ID=12503098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59037635A Pending JPS60181022A (en) | 1984-02-28 | 1984-02-28 | Anti-inflammatory and analgesic composition for mucosa |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60181022A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466452A (en) * | 1991-02-28 | 1995-11-14 | Phytopharm Ltd. | Pharmaceutical compositions for the treatment of skin disorders |
US6676975B2 (en) | 1994-06-24 | 2004-01-13 | Phytotech Limited | Chinese herbal composition for treating eczema and psoriasis |
JP2008105950A (en) * | 2006-10-23 | 2008-05-08 | Pola Chem Ind Inc | Orally administrative composition for arthritis and arthrosis |
EP1859834A4 (en) * | 2005-03-15 | 2009-11-18 | Maruzen Pharm Co Ltd | Anti-inflammatory agent |
EP2223611A1 (en) * | 2007-10-22 | 2010-09-01 | Beijing Dongsheng Agricultural Technology Development (Group) Co., Ltd | Natural nutritional supplementary food of abelmoschus manihot (linn.) medius |
JP2011500065A (en) * | 2007-10-22 | 2011-01-06 | 北京東昇農業技術開発(集団)有限公司 | Natural nutritive foods, troro-aoi seeds (seed) products for pharmaceutical materials |
CN104434621A (en) * | 2014-10-30 | 2015-03-25 | 惠州出入境检验检疫局检验检疫综合技术中心 | Antipyrotic and antiallergic traditional Chinese medicine composition and application thereof in preparation of skin care products |
CN104606267A (en) * | 2015-01-22 | 2015-05-13 | 黄邦成 | Rapid pain relieving liquid |
CN105560308A (en) * | 2015-12-31 | 2016-05-11 | 河南弘烨生物科技有限公司 | Application of Flower of Hibiscus manihot L. in preparation of products for preventing and treating prostate diseases |
-
1984
- 1984-02-28 JP JP59037635A patent/JPS60181022A/en active Pending
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5466452A (en) * | 1991-02-28 | 1995-11-14 | Phytopharm Ltd. | Pharmaceutical compositions for the treatment of skin disorders |
US6676975B2 (en) | 1994-06-24 | 2004-01-13 | Phytotech Limited | Chinese herbal composition for treating eczema and psoriasis |
US7341746B2 (en) | 1994-06-24 | 2008-03-11 | Phytotech Limited | Chinese herbs extract |
US8563054B2 (en) | 2005-03-15 | 2013-10-22 | Maruzen Pharmaceuticals Co., Ltd. | Anti-inflammatory agent |
EP1859834A4 (en) * | 2005-03-15 | 2009-11-18 | Maruzen Pharm Co Ltd | Anti-inflammatory agent |
JP2008105950A (en) * | 2006-10-23 | 2008-05-08 | Pola Chem Ind Inc | Orally administrative composition for arthritis and arthrosis |
EP2223611A4 (en) * | 2007-10-22 | 2010-12-08 | Beijing Dongsheng Agricultural | Natural nutritional supplementary food of abelmoschus manihot (linn.) medius |
JP2011500064A (en) * | 2007-10-22 | 2011-01-06 | 北京東昇農業技術開発(集団)有限公司 | Natural food supplement Toro Aoi Food |
JP2011500065A (en) * | 2007-10-22 | 2011-01-06 | 北京東昇農業技術開発(集団)有限公司 | Natural nutritive foods, troro-aoi seeds (seed) products for pharmaceutical materials |
EP2223611A1 (en) * | 2007-10-22 | 2010-09-01 | Beijing Dongsheng Agricultural Technology Development (Group) Co., Ltd | Natural nutritional supplementary food of abelmoschus manihot (linn.) medius |
CN104434621A (en) * | 2014-10-30 | 2015-03-25 | 惠州出入境检验检疫局检验检疫综合技术中心 | Antipyrotic and antiallergic traditional Chinese medicine composition and application thereof in preparation of skin care products |
CN104434621B (en) * | 2014-10-30 | 2017-10-17 | 惠州出入境检验检疫局检验检疫综合技术中心 | A kind of anti-inflammatory antiallergic traditional Chinese medicine composition and its application in skin care item are prepared |
CN104606267A (en) * | 2015-01-22 | 2015-05-13 | 黄邦成 | Rapid pain relieving liquid |
CN105560308A (en) * | 2015-12-31 | 2016-05-11 | 河南弘烨生物科技有限公司 | Application of Flower of Hibiscus manihot L. in preparation of products for preventing and treating prostate diseases |
CN105560308B (en) * | 2015-12-31 | 2019-11-01 | 河南弘烨生物科技(集团)有限公司 | Flower of JINHUAKUI is preparing the application in the product for preventing and treating prostatic disorders |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Haddadian et al. | A review of Plantago plant | |
Khare | Indian herbal remedies: rational Western therapy, ayurvedic, and other traditional usage, Botany | |
CN108606939B (en) | Composition with oral health care function and application and preparation method thereof | |
JPS60181022A (en) | Anti-inflammatory and analgesic composition for mucosa | |
JPH0477730B2 (en) | ||
CN101396528B (en) | Traditional Chinese medicine composite preparation for treating wind-heat cold | |
CN104873446A (en) | Cinnamon oil containing toothpaste | |
CN111297965A (en) | Traditional Chinese medicine composition for treating chronic nephritis | |
WO2024001141A1 (en) | Use of herba agastachis stomach-calming prescription in preparation of drug for resisting helicobacter pylori | |
CN104997860A (en) | Traditional Chinese medicine preparation for treating duodenal ulcer and preparation method thereof | |
Mascolo et al. | Healing powers of aloes | |
CN107970388A (en) | It is a kind of to be used to treat pharmaceutical composition, preparation of pharyngitis and preparation method thereof, application | |
CN114452319A (en) | A Chinese medicinal gel for preventing and treating mosquito bite, and its preparation method | |
CN110384785B (en) | A topical Chinese medicinal liquid for treating viral common cold, and its preparation method | |
Szyszkowska et al. | The use of medicinal plants in dental treatment | |
CN107569580B (en) | A topical Chinese medicinal composition for treating hemorrhoid, and its preparation method | |
JP2001122795A (en) | Prophylactic and therapeutic agent for infectious disease | |
CN1362259A (en) | Application of nim extract in medicine | |
CN111632080A (en) | Formula for treating drug eruption dermatitis, preparation method and application | |
JP4950551B2 (en) | Gastrointestinal mucosa protective agent | |
KR101440533B1 (en) | A composition comprising herbal extracts for cleaning nasal cavity | |
CN115006491B (en) | Traditional Chinese medicine composition for treating chronic atrophic gastritis and preparation method thereof | |
JPH06107553A (en) | Composition having analgesic function | |
CN114159536B (en) | Pharmaceutical composition, preparation method and application thereof | |
CN109908312B (en) | Hemorrhoid ointment and preparation method thereof |